Along the same line, HMGB1 knockdown in MM cells or in mice led to autophagy inhibition, which was associated with the potentiation of the dexamethasone chemotherapeutic effects, that is, increased apoptosis in vitro and reduced tumour burden in vivo [211]. This evidence concerns the gene HMGB1 and Miyoshi myopathy.